These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12679740)

  • 1. Non-stimulant treatment of attention-deficit/hyperactivity disorder.
    Pliszka SR
    CNS Spectr; 2003 Apr; 8(4):253-8. PubMed ID: 12679740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
    Osland ST; Steeves TD; Pringsheim T
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
    Himpel S; Banaschewski T; Heise CA; Rothenberger A
    Expert Opin Drug Saf; 2005 Mar; 4(2):311-21. PubMed ID: 15794722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in the treatment of ADHD.
    Biederman J; Arnsten AF; Faraone SV; Doyle AE; Spencer TJ; Wilens TE; Weiss MD; Safren SA; Culpepper L
    J Clin Psychiatry; 2006 Jan; 67(1):148-59. PubMed ID: 16426101
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological management of attention-deficit hyperactivity disorder.
    Reeves G; Schweitzer J
    Expert Opin Pharmacother; 2004 Jun; 5(6):1313-20. PubMed ID: 15163276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
    Waxmonsky JG
    Essent Psychopharmacol; 2005; 6(5):262-76. PubMed ID: 16222911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel treatments for attention-deficit/hyperactivity disorder in children.
    Spencer TJ; Biederman J; Wilens TE; Faraone SV
    J Clin Psychiatry; 2002; 63 Suppl 12():16-22. PubMed ID: 12562057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-stimulant medications in the treatment of ADHD.
    Banaschewski T; Roessner V; Dittmann RW; Santosh PJ; Rothenberger A
    Eur Child Adolesc Psychiatry; 2004; 13 Suppl 1():I102-16. PubMed ID: 15322961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T; Steeves T
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
    Bloch MH; Panza KE; Landeros-Weisenberger A; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):884-893. PubMed ID: 19625978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
    Biederman J; Spencer T; Wilens T
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):77-97. PubMed ID: 14733627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovations and recent trends in the treatment of ADHD.
    Madaan V; Kinnan S; Daughton J; Kratochvil CJ
    Expert Rev Neurother; 2006 Sep; 6(9):1375-85. PubMed ID: 17009924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.
    Huang YS; Tsai MH
    CNS Drugs; 2011 Jul; 25(7):539-54. PubMed ID: 21699268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
    Párraga HC; Párraga MI; Harris DK
    Int J Psychiatry Med; 2007; 37(4):415-24. PubMed ID: 18441629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanfacine use in children with attention deficit hyperactivity disorder.
    Cohn LM; Caliendo GC
    Ann Pharmacother; 1997; 31(7-8):918-9. PubMed ID: 9220058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M; Munda B; Svab V; Locatelli I
    J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
    Buoli M; Serati M; Cahn W
    Expert Rev Neurother; 2016; 16(2):131-44. PubMed ID: 26693882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current pharmacotherapy of attention deficit hyperactivity disorder.
    Reddy DS
    Drugs Today (Barc); 2013 Oct; 49(10):647-65. PubMed ID: 24191257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs for the treatment of attention-deficit/hyperactivity disorder.
    Pataki CS; Feinberg DT; McGough JJ
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):293-302. PubMed ID: 15571486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.